로딩 중…
지수 로딩 중…
Sionna Therapeutics Inc. Common Stock
SION· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$49.26+4.52%
2026-08-03
Financials
Valuation Metrics
Sionna Therapeutics Inc. Common Stock's Market Cap is $2.22B. At end of 2025 it was $1.64B. Ranked #1979 of 3,112 in US market (top 64%), #747 of 1,445 on NASDAQ (top 52%), #126 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 47%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.22B | US#1,979/3,112 Sec#126/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-86M | US—/3,112 Sec—/269 |
| Total Assets | $305M | US#2,892/3,112 Sec#210/269 |
| Net Assets | $288M | US#2,564/3,112 Sec#160/269 |
| Value | ||
| P/B | 7.72x | US#2,471/3,112 Sec#184/269 |
| FCF Yield | -3.24% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -29.69% | US#2,612/3,112 Sec#125/269 |
| ROA | -28.05% | US#2,857/3,112 Sec#157/269 |
| Financial Health | ||
| Debt Ratio | 5.84% | US#59/3,112 Sec#26/269 |
| Total Debt | $8M | US#2,801/3,112 Sec#205/269 |
| FCF | $-72M | US#2,526/3,112 Sec#129/269 |
| Cash | $63M | US#2,474/3,112 Sec#212/269 |
| Current Ratio | 22.60x | US#112/3,112 Sec#25/269 |
| Performance | ||
| 1Y Return | 191.13% | US#114/3,112 Sec#41/269 |
| 1M Return | 11.98% | US#418/3,112 Sec#17/269 |
| From 52W High | -4.48% | US#502/3,112 Sec#20/269 |
| 1Y MDD | -27.07% | US#1,158/3,112 Sec#66/269 |
| Trading | ||
| Volume | 503,594 shares | US#2,070/3,112 Sec#201/269 |
| Trading Value | $24M | US#1,860/3,112 Sec#133/269 |